Business
ChromaDex to Report Third Quarter 2023 Financial Results on Wednesday, November 8, 2023
LOS ANGELES--(BUSINESS WIRE)-- ChromaDex Corp. (NASDAQ:CDXC) (“the Company”) a global bioscience company dedicated to healthy aging, announced that it will
About this update from Niagen Bioscience, Inc.
[{"type":"text","content":" LOS ANGELES--(BUSINESS WIRE)--\nChromaDex Corp. (NASDAQ:CDXC) (“the Company”) a global bioscience company dedicated to healthy aging, announced that it will hold a conference call on Wednesday, November 8, 2023 at 4:30 p.m. ET to discuss its financial results for the third quarter, which ended September 30, 2023. The financial results will be reported in a press release after the close of regular stock market trading hours on the same day as the conference call.\n\n\nInvestor Conference Call:\n\n\nChromaDex management will host an investor conference call to discuss third quarter 2023 results and provide a general business update on Wednesday, November 8, at 4:30 p.m. ET.\n\n\nParticipants should call in at least 10 minutes prior to the call. The dial-in information is as follows:\n\n\nDate: Wednesday, November 8, 2023\nTime: 4:30 p.m. ET (1:30 p.m. PT)\nToll-free dial-in number: 1-888-330-2446\nConference ID: 4126168\nWebcast link: ChromaDex Third Quarter 2023 Earnings Conference Call\n\n\nThe conference call will be broadcast live and available for replay here and via the investor relations section of the Company’s website at www.chromadex.com.\n\n\nA replay of the conference call will be available from 7:30 p.m. ET on November 8, 2023, to 11:59 p.m. ET on November 15, 2023.\n\n\nToll-free replay number: 1-800-770-2030\nReplay ID: 4126168\n\n\nImportant Note on Forward Looking Statements:\n\n\nThis release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended. Statements that are not a description of historical facts constitute forward-looking statements and may often, but not always, be identified by the use of such words as “expects,” “anticipates,” “intends” “estimates,” “plans,” “potential,” “possible,” “probable,” “believes” “seeks,” “may,” “will,” “should,” “could,” “predicts,” “projects,” “continue,” “would” or the negative of such terms or other similar expressions. Risks that contribute to the uncertain nature of the forward-looking statements include, but are not limited to, inflationary conditions and adverse economic conditions; our history of operating losses and need to obtain additional financing; the growth and profitability of our product sales; our ability to maintain sales, marke...